Metraipolis › archive › dc_397eb5e240e2

Efficacy and safety of tyrosine kinase inhibitors in advanced hepatocellular carcinoma patients with Child-Pugh A and B cirrhosis: a meta-analysis — Europe PMC PMID:41890893

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41890893
DOI: 10.3389/fphar.2026.1690890
License (as archived): solo-consultazione
Archived: 2026-11-04T13:08:44.348Z
SHA-256 of the archived text: 053795c8a291e3c71cc4fd1ea4eaf144a12947a58db0f25d44933ff08c9ff9fc
Stable URL of this page: https://metraipolis.com/documento/dc_397eb5e240e2

How to cite

Efficacy and safety of tyrosine kinase inhibitors in advanced hepatocellular carcinoma patients with Child-Pugh A and B cirrhosis: a meta-analysis — Europe PMC PMID:41890893 — Europe PMC (en), https://europepmc.org/article/MED/41890893 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_397eb5e240e2 (Metraipolis archive dc_397eb5e240e2, sha256 053795c8a291e3c71cc4fd1ea4eaf144a12947a58db0f25d44933ff08c9ff9fc)

BibTeX

@misc{dc397eb5e240e2,
  title = {Efficacy and safety of tyrosine kinase inhibitors in advanced hepatocellular carcinoma patients with Child-Pugh A and B cirrhosis: a meta-analysis — Europe PMC PMID:41890893},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41890893},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_397eb5e240e2; sha256 053795c8a291e3c71cc4fd1ea4eaf144a12947a58db0f25d44933ff08c9ff9fc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41890893. Agents can read the archived copy with the MCP tool read_document.